{
  "@context": "http://id.who.int/icd/contexts/contextForLinearizationEntity.json",
  "@id": "http://id.who.int/icd/release/11/2024-01/mms/292680542",
  "parent": [
    "http://id.who.int/icd/release/11/2024-01/mms/705200672"
  ],
  "child": [
    "http://id.who.int/icd/release/11/2024-01/mms/1237292304",
    "http://id.who.int/icd/release/11/2024-01/mms/292680542/other"
  ],
  "browserUrl": "https://icd.who.int/browse/2024-01/mms/en#292680542",
  "code": "",
  "source": "http://id.who.int/icd/entity/292680542",
  "classKind": "block",
  "blockId": "BlockL3-EF5",
  "codeRange": "EF50-EF5Y",
  "foundationChildElsewhere": [
    {
      "label": {
        "@language": "en",
        "@value": "Thrombotic thrombocytopenic purpura"
      },
      "foundationReference": "http://id.who.int/icd/entity/1708277768",
      "linearizationReference": "http://id.who.int/icd/release/11/2024-01/mms/1708277768"
    },
    {
      "label": {
        "@language": "en",
        "@value": "Antiphospholipid syndrome"
      },
      "foundationReference": "http://id.who.int/icd/entity/1173370808",
      "linearizationReference": "http://id.who.int/icd/release/11/2024-01/mms/1173370808"
    },
    {
      "label": {
        "@language": "en",
        "@value": "Disseminated intravascular coagulation"
      },
      "foundationReference": "http://id.who.int/icd/entity/1622289887",
      "linearizationReference": "http://id.who.int/icd/release/11/2024-01/mms/1622289887"
    },
    {
      "label": {
        "@language": "en",
        "@value": "Cryoglobulinaemic vasculitis"
      },
      "foundationReference": "http://id.who.int/icd/entity/55133785",
      "linearizationReference": "http://id.who.int/icd/release/11/2024-01/mms/55133785"
    }
  ],
  "title": {
    "@language": "en",
    "@value": "Dermatoses attributable to hyperviscosity or microvascular occlusion"
  },
  "definition": {
    "@language": "en",
    "@value": "A range of disorders characterised by vascular occlusion but attributable not to primary vascular inflammation but to intravascular occlusion."
  }
}